A review of prostaglandins and the treatment of tumor metastasis.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001792:Blood Platelets / Q000502:physiology; D002401:Cathepsin B; D002403:Cathepsins / Q000502:physiology; D002460:Cell Line; D002462:Cell Membrane / Q000502:physiology; D011464:Epoprostenol / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D009362:Neoplasm Metastasis / Q000503:physiopathology*; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000503:physiopathology; D009360:Neoplastic Cells, Circulating; D010974:Platelet Aggregation; D011453:Prostaglandins / Q000502:physiology*; D011720:Pyrazoles / Q000627:therapeutic use; D047069:Pyrazolones; D051381:Rats; D012701:Serotonin / Q000502:physiology; D013928:Thromboxane A2 / Q000502:physiology
D001095:Arachidonic Acids; D011453:Prostaglandins; D011720:Pyrazoles; D047069:Pyrazolones; D016718:Arachidonic Acid; D012701:Serotonin; D013928:Thromboxane A2; D011464:Epoprostenol; D002403:Cathepsins; D002401:Cathepsin B; C018845:nafazatrom